Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bupivacaine 250mg/250ml (0.1%) infusion bags
1502010C0AAAYAY
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Bupivacaine 312.5mg/250ml (0.125%) infusion bags
1502010C0AAALAL
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Bupivacaine 500mg/500ml (0.1%) / Fentanyl 1mg/500ml inf bags
1502010Z0AAACAC
|
Bupivac hydrochloride and fentanyl citrate | Bupivacaine hydrochloride and fentanyl citrate | Anaesthesia | No data available |
|
Bupivacaine 75mg/10ml (0.75%) inj ampoules
1502010C0AAAEAE
|
Bupivac hydrochloride | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Children's 3 Months Plus teething gel sugar free
1502010J0BRAAEK
|
Boots (Lidocaine hydrochloride) | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Chirocaine 50mg/10ml solution for injection ampoules
1502010V0BBABAB
|
Chirocaine | Levobupivacaine hydrochloride | Anaesthesia | No data available |
|
Chloroprocaine 400mg/20ml solution for injection vials
1502010AAAAABAB
|
Chloroprocaine hydrochloride | Chloroprocaine hydrochloride | Anaesthesia | No data available |
|
Chloroprocaine 50mg/5ml solution for injection ampoules
1502010AAAAAAAA
|
Chloroprocaine hydrochloride | Chloroprocaine hydrochloride | Anaesthesia | No data available |
|
Cisatracurium besilate 10mg/5ml inj ampoules
1501050W0AAABAB
|
Cisatracurium | Cisatracurium | Anaesthesia | No data available |
|
Cisatracurium besilate 10mg/5ml solution for injection vials
1501050W0AAAFAF
|
Cisatracurium | Cisatracurium | Anaesthesia | No data available |
|
Cisatracurium besilate 150mg/30ml inj vials
1501050W0AAADAD
|
Cisatracurium | Cisatracurium | Anaesthesia | No data available |
|
Cisatracurium besilate 20mg/10ml inj ampoules
1501050W0AAACAC
|
Cisatracurium | Cisatracurium | Anaesthesia | No data available |
|
Cisatracurium besilate 20mg/10ml inj vials
1501050W0AAAEAE
|
Cisatracurium | Cisatracurium | Anaesthesia | No data available |
|
Cisatracurium besilate 5mg/2.5ml inj ampoules
1501050W0AAAAAA
|
Cisatracurium | Cisatracurium | Anaesthesia | No data available |
|
Cisatracurium besilate 5mg/2.5ml inj vials
1501050W0AAAGAG
|
Cisatracurium | Cisatracurium | Anaesthesia | No data available |
|
Citanest 1% solution for injection 20ml vials
1502010S0BBACAC
|
Citanest | Prilocaine hydrochloride | Anaesthesia | No data available |
|
Citanest 1% solution for injection 50ml vials
1502010S0BBADAD
|
Citanest | Prilocaine hydrochloride | Anaesthesia | No data available |
|
Citanest 3% with Octapressin Dental 0.054units/1.8ml inj
1502010S0BBAHAI
|
Citanest | Prilocaine hydrochloride | Anaesthesia | No data available |
|
Cocaine 10% mouthwash
1502010G0AAAIAI
|
Cocaine | Cocaine | Anaesthesia | No data available |
|
Cocaine 10% nasal drops
1502010F0AAAXAX
|
Cocaine hydrochloride (Anaesthetic) | Cocaine hydrochloride | Anaesthesia | No data available |
|
Cocaine 10% spray
1502010G0AAARAR
|
Cocaine | Cocaine | Anaesthesia | No data available |
|
Cocaine 25% oromucosal paste
1502010G0AAATAT
|
Cocaine | Cocaine | Anaesthesia | No data available |
|
Cocaine 4% topical solution
1502010G0AAAUAU
|
Cocaine | Cocaine | Anaesthesia | No data available |
|
Cocaine 5% mouthwash
1502010G0AAAAAA
|
Cocaine | Cocaine | Anaesthesia | No data available |
|
Cocaine 5% nasal spray
1502010G0AAASAS
|
Cocaine | Cocaine | Anaesthesia | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.